HERBALIFE LTD's ticker is HLF and the CUSIP is G4412G101. A total of 212 filers reported holding HERBALIFE LTD in Q2 2022. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,165,008 | +317.1% | 1,298,428 | +294.7% | 0.00% | – |
| Q2 2023 | $4,355,497 | -58.5% | 328,965 | -49.6% | 0.00% | -100.0% |
| Q1 2023 | $10,504,188 | +9.0% | 652,434 | +0.7% | 0.00% | +100.0% |
| Q4 2022 | $9,641,228 | +46.3% | 647,932 | +95.6% | 0.00% | 0.0% |
| Q3 2022 | $6,590,000 | -15.5% | 331,308 | -13.1% | 0.00% | 0.0% |
| Q2 2022 | $7,797,000 | -36.4% | 381,304 | -5.5% | 0.00% | -50.0% |
| Q1 2022 | $12,254,000 | -55.8% | 403,603 | -40.4% | 0.00% | +100.0% |
| Q4 2021 | $27,710,000 | -19.2% | 676,998 | -16.4% | 0.00% | -80.0% |
| Q3 2021 | $34,311,000 | +0.2% | 809,600 | +24.6% | 0.01% | 0.0% |
| Q2 2021 | $34,253,000 | +39.0% | 649,600 | +16.9% | 0.01% | +25.0% |
| Q1 2021 | $24,643,000 | -50.8% | 555,503 | -46.7% | 0.00% | 0.0% |
| Q4 2020 | $50,086,000 | +132.1% | 1,042,360 | +125.4% | 0.00% | 0.0% |
| Q3 2020 | $21,576,000 | -20.1% | 462,508 | -22.9% | 0.00% | -33.3% |
| Q2 2020 | $26,988,000 | +35.7% | 600,016 | -12.0% | 0.01% | -14.3% |
| Q1 2020 | $19,887,000 | -56.2% | 682,001 | -28.5% | 0.01% | -46.2% |
| Q4 2019 | $45,452,000 | +21.6% | 953,476 | -3.4% | 0.01% | +8.3% |
| Q3 2019 | $37,370,000 | -86.1% | 987,047 | -84.2% | 0.01% | -63.6% |
| Q2 2019 | $267,925,000 | +103.2% | 6,265,846 | +151.8% | 0.03% | -38.9% |
| Q1 2019 | $131,868,000 | -38.3% | 2,488,534 | -31.3% | 0.05% | -35.7% |
| Q4 2018 | $213,664,000 | +55.0% | 3,624,500 | +43.4% | 0.08% | +82.6% |
| Q3 2018 | $137,869,000 | +8.7% | 2,527,400 | +7.0% | 0.05% | +4.5% |
| Q2 2018 | $126,855,000 | -30.6% | 2,361,400 | +26.0% | 0.04% | -32.3% |
| Q1 2018 | $182,727,000 | -12.2% | 1,874,700 | -39.0% | 0.06% | -11.0% |
| Q4 2017 | $208,056,000 | -35.5% | 3,072,300 | -35.4% | 0.07% | -41.6% |
| Q3 2017 | $322,667,000 | +35.6% | 4,757,000 | +42.6% | 0.12% | +19.0% |
| Q2 2017 | $237,928,000 | +12.9% | 3,335,600 | -8.0% | 0.10% | -0.9% |
| Q1 2017 | $210,711,000 | -29.1% | 3,624,200 | -41.3% | 0.11% | -29.8% |
| Q4 2016 | $297,154,000 | -6.5% | 6,172,700 | +20.4% | 0.15% | -1.9% |
| Q3 2016 | $317,704,000 | -3.7% | 5,125,085 | -9.1% | 0.15% | -13.0% |
| Q2 2016 | $329,858,000 | -10.6% | 5,635,714 | -6.0% | 0.18% | -9.7% |
| Q1 2016 | $369,048,000 | +18.7% | 5,994,946 | +3.3% | 0.20% | +36.1% |
| Q4 2015 | $311,037,000 | -13.6% | 5,800,757 | -12.2% | 0.14% | -7.1% |
| Q3 2015 | $359,973,000 | -0.8% | 6,605,011 | +0.3% | 0.16% | +0.6% |
| Q2 2015 | $362,695,000 | -2.0% | 6,583,680 | -23.9% | 0.15% | -8.3% |
| Q1 2015 | $370,092,000 | -8.8% | 8,655,121 | -19.6% | 0.17% | +5.0% |
| Q4 2014 | $406,022,000 | +3.6% | 10,769,836 | +20.3% | 0.16% | +6.7% |
| Q3 2014 | $391,747,000 | -8.4% | 8,954,200 | +35.1% | 0.15% | -18.5% |
| Q2 2014 | $427,778,000 | -15.0% | 6,628,128 | -24.6% | 0.18% | -21.0% |
| Q1 2014 | $503,407,000 | -50.2% | 8,790,067 | -31.6% | 0.23% | -50.1% |
| Q4 2013 | $1,011,683,000 | +14.3% | 12,854,915 | +1.4% | 0.47% | -0.4% |
| Q3 2013 | $884,910,000 | +196.1% | 12,683,242 | +91.6% | 0.47% | +177.5% |
| Q2 2013 | $298,863,000 | – | 6,620,792 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BlueDrive Global Investors LLP | 850,028 | $25,807,000 | 11.41% |
| Alua Capital Management LP | 5,353,223 | $162,524,000 | 11.12% |
| Route One Investment Company, L.P. | 10,043,232 | $304,913,000 | 9.50% |
| Bronte Capital Management Pty Ltd. | 2,962,635 | $89,946,000 | 7.56% |
| WINDACRE PARTNERSHIP LLC | 10,003,500 | $303,706,000 | 6.38% |
| CAS Investment Partners, LLC | 2,907,762 | $88,280,000 | 5.91% |
| Deccan Value Investors L.P. | 3,062,839 | $92,988,000 | 4.74% |
| JABODON PT CO | 170,332 | $5,171,000 | 2.35% |
| 683 Capital Management, LLC | 1,440,597 | $43,737,000 | 2.34% |
| Patient Capital Management, LLC | 194,300 | $5,899,000 | 2.00% |